Intensity Therapeutics Inc
(INTS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 08-1997 | 05-1997 | 02-1997 | 11-1996 | 08-1996 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 5,927 | 7,922 | 5,812 | 4,126 | 3,751 |
| TOTAL | $5,927 | $7,922 | $5,812 | $4,126 | $3,751 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 17,956 | N/A | N/A |
| Investments And Advances | 36,840 | 36,539 | 24,627 | 34,047 | 29,901 |
| Other Non-Current Assets | 4,870 | 5,196 | 5,773 | 5,538 | 7,727 |
| TOTAL | $41,710 | $41,735 | $48,356 | $39,585 | $37,628 |
| Total Assets | $47,637 | $49,657 | $54,168 | $43,711 | $41,379 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,766 | 4,511 | 4,143 | 4,413 | 3,823 |
| Accrued Expenses | 10,254 | 8,874 | 7,921 | 9,083 | 6,914 |
| Other current liabilities | 13,501 | 17,949 | 12,621 | 10,680 | 9,575 |
| TOTAL | $30,259 | $32,352 | $26,127 | $24,598 | $20,669 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 249 | 81 | 203 | 254 | 127 |
| TOTAL | $249 | $81 | $203 | $254 | $127 |
| Total Liabilities | $30,508 | $32,433 | $26,330 | $24,852 | $20,796 |
| Shareholders' Equity | |||||
| Common Shares | 62,488 | 62,030 | 61,158 | 59,590 | 58,583 |
| Other shareholders' equity | -1,216 | -786 | -982 | 158 | -70 |
| TOTAL | $61,272 | $61,244 | $60,176 | $59,748 | $58,513 |
| Total Liabilities And Equity | $91,780 | $93,677 | $86,506 | $84,600 | $79,309 |